[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.176.252. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 24, 2010

Risks From Antipsychotic Medications in Children and Adolescents—Reply

JAMA. 2010;303(8):729-731. doi:10.1001/jama.2010.133

In Reply: Dr Mangurian and colleagues note the importance of racial/ethnic influences on metabolic outcomes in psychiatrically ill patients. Race/ethnicity has been associated with cardiometabolic risk status in the general population and in psychiatric patients,1 including the control of risk factors.2 However, in most randomized controlled trials, members of minority ethnic groups are underrepresented. We acknowledge that in this naturalistic cohort study the choice of specific antipsychotic medications was likely influenced, at least in part, by preexisting metabolic risk factors. Unfortunately, the number of children and adolescents who were antipsychotic-naive in our cohort study was not large enough to allow for meaningful subgroup analysis.

First Page Preview View Large
First page PDF preview
First page PDF preview
×